Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes

Overview of attention for article published in Alzheimer's Research & Therapy, April 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 87 Dimensions

Readers on

mendeley: 107 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 1 news story.

Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes.

Alzforum, 10 Apr 2020

Hierro-Bujalance C, Infante-Garcia C, Del Marco A, Herrera M, Carranza-Naval MJ, Suarez J, Alves-Martinez P, Lubian-Lopez S…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.